Osaic Holdings’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
Bought
Maintained
Sold
Other funds holding CERE
Osaic Holdings's CERE Position: Q3 2024 in Review
Osaic Holdings sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 175 shares — an estimated $7.16K sold.
Osaic Holdings first reported a position in CERE in Q4 2021 and held it in 11 quarters. The position peaked at $10K in Q1 2022. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.
- Osaic Holdings reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
- Osaic Holdings sold 175 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $7.16K.
- Osaic Holdings first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q4 2021 and held it in 11 quarters.
- Osaic Holdings's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $10K in Q1 2022.
- 2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.
Based on Osaic Holdings's 13F filing for Q3 2024, filed 13 Nov 2024.